A biomaterial is any substance of metallic, polymer, ceramic or natural origin that is suitable for introducing into living tissue as an implant without adversely affecting the patient. The biomaterial implants have been enormously successful and have enhanced the life of millions of patients.

The global Implantable Biomaterial market was valued at 13900 million US$ in 2018 and will reach 26700 million US$ by the end of 2025, growing at a CAGR of 8.5% during 2019-2025.
This report focuses on Implantable Biomaterial volume and value at global level, regional level and company level. From a global perspective, this report represents overall Implantable Biomaterial market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Implantable Biomaterial in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Implantable Biomaterial manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Carpenter Technology
Collagen
Corbion
Evonik Industries
Johnson Matthey
Landec
Materion
Morgan Advanced Materials
Royal Dsm Biomedical
Solvay
Victrex

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Metals and Metal Alloys
Synthetic Polymers
Ceramics
Natural Biomaterials
Composites

Segment by Application
Cardiovascular
Orthopedic Application
Dental
Plastic Surgery
Wound Healing
Others